Results of 281 Consecutive Total Laparoscopic Roux-en-Y Gastric Bypasses to Treat Morbid Obesity
Top Cited Papers
- 1 May 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 235 (5), 640-647
- https://doi.org/10.1097/00000658-200205000-00005
Abstract
To determine the safety and efficacy of laparoscopic Roux-en-Y gastric bypass for the treatment of morbid obesity. Laparoscopic Roux-en-Y gastric bypass is a new and technically challenging surgical procedure that requires careful study. The authors attempted total laparoscopic Roux-en-Y gastric bypass in 281 consecutive patients. Procedures included 175 proximal bypasses, 12 long-limb bypasses, and 9 revisional procedures from previous bariatric operations. The gastrojejunostomy and jejunojejunostomy were primarily constructed using linear stapling techniques. Eight patients required conversion to an open procedure (2.8%). The mean age of the patients was 41.6 years (range 15–71) and 87% were female. The mean preoperative body mass index was 48.1 kg/m2. The operative time decreased significantly from 234 ± 77 minutes in the first quartile to 162 ± 42 minutes in the most recent quartile. Postoperative length of stay averaged 4 days (range 2–91), with 75% of patients discharged within 3 days. The median hospital stay was 2 days. No patient died after surgery. Complications included three (1.5%) major wound infections (each followed a reoperation for a complication or open conversion), incisional hernia in 5 patients (1.8%), and anastomotic leak with peritonitis in 14 patients (5.1%). Three gastrojejunal leaks were managed without surgery, four by laparoscopic repair/drainage, and three by open repair/drainage. Only three patients had anastomotic leaks in the most recent 164 procedures (1.8%) since the routine use of a two-layer anastomotic technique. Data at 1 year after surgery were available in 69 of 96 (72%) patients (excludes revisions). Weight loss at one year was 70 ± 5% of excess weight. Most comorbid conditions resolved by 1 year after surgery; notably, 88% of patients with diabetes no longer required medications. Laparoscopic gastric bypass demonstrates excellent weight loss and resolution of comorbidities with a low complication rate. The learning curve is evident: operative time and leaks decreased with experience and improved techniques. The primary advantage is an extremely low risk of wound complications, including infection and hernia.Keywords
This publication has 11 references indexed in Scilit:
- GASTRIC BYPASSSurgical Clinics of North America, 2001
- Outcomes After Laparoscopic Roux-en-Y Gastric Bypass for Morbid ObesityAnnals of Surgery, 2000
- Laparoscopic Roux-en-Y Gastric Bypass for Morbid ObesityArchives of Surgery, 2000
- A comparison study of laparoscopic versus open gastric bypass for morbid obesityJournal of the American College of Surgeons, 2000
- Laparoscopic Gastric Bypass, Roux en-Y - 500 Patients: Technique and Results, with 3-60 month follow-upObesity Surgery, 2000
- A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight lossThe American Journal of Surgery, 1995
- Laparoscopic Gastric Bypass, Roux-en-Y: Preliminary Report of Five CasesObesity Surgery, 1994
- Gastric bypass for treating severe obesityThe American Journal of Clinical Nutrition, 1992
- Surgical treatment of obesity and its effect on diabetes: 10-y follow-upThe American Journal of Clinical Nutrition, 1992
- A Randomized Prospective Trial of Gastric Bypass Versus Vertical Banded Gastroplasty for Morbid Obesity and their Effects on Sweets Versus Non-Sweets EatersAnnals of Surgery, 1987